Last week, over 3 days, we joined partners from ADDISS at the 4th General meeting of TIMESPAN in #Copenhagen . Excellent & interesting work on #ADHD #Diabetes #Obesity #cardiovascular and #adhdsupport .
More info lnkd.in/eDuKDUm3

Amazing! My supervisor Helga Zoega presented a poster TIMESPAN conference in Copenhagen, showcasing our findings from my MPH thesis UNSW on the link btw #ADHD and cardiovascular medication use in adulthood. Huge thanks to Medicines Intelligence CRE! Can't wait to publish our work🥰

🌟 Reflecting on last week’s General Assembly meeting! 🧠
We convened in Copenhagen & engaged in in-depth discussions about #ADHDresearch .
A highlight: the ECS #posterwalk
Inspiring discussions & strategic planning drove our project forward. Huge thanks to all! 💪 #EUfunded

Just the greatest honour to be a partner in this amazing project.

Presented by Henrik Larsson, uncovering the intricate link btw #ADHD and cardiometabolic health through groundbreaking international #research collaboration with TIMESPAN. Privileged to be part of it, thanks to Helga Zoega UNSW. Stay tuned for transformative insights😉

EASO is pleased to support the 5-year EU-funded TIMESPAN project, aiming to foster improvement in the clinical management of adults living with #ADHD & co-occurring cardiometabolic disease, including #obesity .

Learn about the project:
easo.org/timespan/

Horizon Europe🇪🇺

After two productive planning sessions dedicated to work package 8: #dissemination , communication, guideline development, TIMESPAN coordinator Henrik Larsson now concluded this fourth General Assembly Meeting. 🙌
Thanks to all for your inputs & participation
ADDISS

Productive afternoon with two insightful planning sessions wrapped up! 🧠 Excited for the strategies discussed and the actions to come.
#ADHD #TIMESPAN

Our next speakers are @Yanli_James and Eric Barnett with an update on #predictivemodelling .

They aim to develop algorithms utilizing deep learning neural networks to accurately predict:

➡cardiometabolic disease risks in #ADHD patients

➡treatment discontinuity in patients

We continue our agenda with a presentation by Ditte Demontis. This work package aims to advance our understanding of the biological mechanisms underpinning #ADHD treatment discontinuation.
#riskscore

Next up: @Hayley_Denyer presenting the #ARTCARMA study. Investigating #ADHD medication & physical activity's impact on cardiometabolic diseases like #obesity #Type2diabetes via wearable devices and active monitoring in 200 adults.

ADHD Remote Technology (ART) KCL @Empatica Toni Ramos-Quiroga

Kari Klungsøyr, from Institutt for global helse og samfunnsmedisin is kicking off the next session, dedicated to describing the patterns of treatment continuity/discontinuity in individuals with #ADHD and cardiometabolic diseases, like #obesity or #type2diabetes .

Next on our agenda, we'll be listening to #ZhengChang , whose work package aims to answer the question: Is ADHD medication in combination with medication for cardiometabolic diseases, like #obesity , #type2diabetes , safe and effective? 🧠💊
#TIMESPAN

Henrik Larsson kicking off the first full meeting day for TIMESPAN in Copenhagen!

We are looking forward to hearing the updates from our TIMESPAN colleagues and presenting about ART-CARMA data collection📱⌚️

And now, let’s dive straight into the topic: Catharina Hartman presents updates on the work package on #epidemiology : Which impact does #ADHD have on patients with cardiometabolic diseases, like #obesity & #Type2diabetes ? How can we optimize care for these patients? 💡

We start into this full meeting day with a warm welcome from TIMESPAN coordinator Henrik Larsson.

He laid out the goals for this meeting. 🙌

Many TIMESPAN consortia partners are working on this project

During the evening, TIMESPAN’s #EarlyCareer Researchers have presented and discussed their research in a #posterwalk . Members of TIMESPAN’s Impact and Innovation Board provided valuable feedback!
Thanks to each and every one for your hard work 🙌
#ECS #Training #ADHD

We dive into our General Assembly meeting with a #masterclass session given by TIMESPAN coordinator Henrik Larsson and #ZhengChang on “Studies of cardiovascular risk in #ADHD using registers - Clinical and practical considerations”

#RegistryData #Pharmacoepi

Looking forward to participating in the TIMESPAN Consortium and 4th General Assembly Meeting today in #Copenhagen 🇩🇰

We’ll discuss our progress, achievements to date, and plan for the year to come.
#adultADHD #scientificresearch #Horizon2020